| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.62e-04 | 9 | 45 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 5.33e-04 | 16 | 45 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 6.78e-04 | 18 | 45 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 7.57e-04 | 19 | 45 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 8.40e-04 | 20 | 45 | 2 | GO:0070993 | |
| Domain | Sel1 | 6.78e-07 | 8 | 44 | 3 | PF08238 | |
| Domain | Sel1-like | 1.01e-06 | 9 | 44 | 3 | IPR006597 | |
| Domain | EIF3C_N_dom | 5.42e-06 | 2 | 44 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 5.42e-06 | 2 | 44 | 2 | PF05470 | |
| Domain | EIF3C | 5.42e-06 | 2 | 44 | 2 | IPR027516 | |
| Domain | zf-RNPHF | 1.62e-05 | 3 | 44 | 2 | PF08080 | |
| Domain | Znf_CHHC | 1.62e-05 | 3 | 44 | 2 | IPR012996 | |
| Domain | SEL1 | 1.51e-04 | 8 | 44 | 2 | SM00671 | |
| Domain | Kelch | 3.44e-04 | 58 | 44 | 3 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.62e-04 | 59 | 44 | 3 | IPR011043 | |
| Domain | Kelch_1 | 5.98e-04 | 70 | 44 | 3 | PF01344 | |
| Domain | Kelch_1 | 5.98e-04 | 70 | 44 | 3 | IPR006652 | |
| Domain | PINT | 6.37e-04 | 16 | 44 | 2 | SM00088 | |
| Domain | PCI_dom | 7.21e-04 | 17 | 44 | 2 | IPR000717 | |
| Domain | PCI | 7.21e-04 | 17 | 44 | 2 | PF01399 | |
| Domain | FGF | 1.22e-03 | 22 | 44 | 2 | SM00442 | |
| Domain | FGF | 1.22e-03 | 22 | 44 | 2 | PF00167 | |
| Domain | HBGF_FGF | 1.22e-03 | 22 | 44 | 2 | PS00247 | |
| Domain | Fibroblast_GF_fam | 1.22e-03 | 22 | 44 | 2 | IPR002209 | |
| Domain | IL-1_fam/FGF_fam | 1.33e-03 | 23 | 44 | 2 | IPR028142 | |
| Domain | RRM_1 | 1.43e-03 | 208 | 44 | 4 | PF00076 | |
| Domain | RRM | 1.67e-03 | 217 | 44 | 4 | SM00360 | |
| Domain | ACR | 1.83e-03 | 27 | 44 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 1.83e-03 | 27 | 44 | 2 | IPR006586 | |
| Domain | RRM_dom | 1.97e-03 | 227 | 44 | 4 | IPR000504 | |
| Domain | RRM | 2.07e-03 | 230 | 44 | 4 | PS50102 | |
| Domain | TPR-like_helical_dom | 2.17e-03 | 233 | 44 | 4 | IPR011990 | |
| Domain | - | 2.56e-03 | 244 | 44 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 3.13e-03 | 258 | 44 | 4 | IPR012677 | |
| Domain | Cytokine_IL1-like | 3.25e-03 | 36 | 44 | 2 | IPR008996 | |
| Domain | Peptidase_M12B_N | 3.80e-03 | 39 | 44 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.80e-03 | 39 | 44 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 4.00e-03 | 40 | 44 | 2 | PS00427 | |
| Domain | Reprolysin | 4.00e-03 | 40 | 44 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 4.00e-03 | 40 | 44 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.00e-03 | 40 | 44 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 4.00e-03 | 40 | 44 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 4.20e-03 | 41 | 44 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 4.20e-03 | 41 | 44 | 2 | IPR001762 | |
| Domain | BTB-kelch_protein | 4.61e-03 | 43 | 44 | 2 | IPR017096 | |
| Domain | Pept_M10_metallopeptidase | 4.61e-03 | 43 | 44 | 2 | IPR001818 | |
| Domain | - | 5.71e-03 | 48 | 44 | 2 | 2.120.10.80 | |
| Domain | TPR_2 | 6.18e-03 | 50 | 44 | 2 | PF07719 | |
| Domain | TPR_2 | 6.18e-03 | 50 | 44 | 2 | IPR013105 | |
| Domain | SOLCAR | 6.93e-03 | 53 | 44 | 2 | PS50920 | |
| Domain | - | 6.93e-03 | 53 | 44 | 2 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 6.93e-03 | 53 | 44 | 2 | IPR018108 | |
| Domain | Mito_carr | 6.93e-03 | 53 | 44 | 2 | PF00153 | |
| Domain | Mt_carrier_dom | 6.93e-03 | 53 | 44 | 2 | IPR023395 | |
| Pubmed | 3.32e-07 | 11 | 45 | 3 | 21900255 | ||
| Pubmed | 4.42e-07 | 12 | 45 | 3 | 37463454 | ||
| Pubmed | Tandem immunoprecipitation approach to identify HIV-1 Gag associated host factors. | 1.12e-06 | 16 | 45 | 3 | 24690621 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 1.64e-06 | 2 | 45 | 2 | 36157221 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 3.06e-06 | 22 | 45 | 3 | 18377426 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 10456323 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 14980514 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 21068389 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 7499401 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 10504338 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLC25A22 EIF3C PAXBP1 PC NSD2 CTR9 HNRNPH1 NDUFV1 HNRNPH3 EIF3CL | 1.11e-05 | 1425 | 45 | 10 | 30948266 |
| Pubmed | 1.23e-05 | 109 | 45 | 4 | 29511296 | ||
| Pubmed | 1.59e-05 | 244 | 45 | 5 | 29884807 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.92e-05 | 254 | 45 | 5 | 28431233 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.62e-05 | 271 | 45 | 5 | 32433965 | |
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 31704785 | ||
| Pubmed | 3.42e-05 | 7 | 45 | 2 | 25846207 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.99e-05 | 147 | 45 | 4 | 28977470 | |
| Pubmed | 4.49e-05 | 503 | 45 | 6 | 16964243 | ||
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 24003236 | ||
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 21292980 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 6.63e-05 | 1082 | 45 | 8 | 38697112 | |
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 16286006 | ||
| Pubmed | 7.32e-05 | 10 | 45 | 2 | 25912421 | ||
| Pubmed | Conservation and diversity of eukaryotic translation initiation factor eIF3. | 7.32e-05 | 10 | 45 | 2 | 8995409 | |
| Pubmed | 7.42e-05 | 551 | 45 | 6 | 34728620 | ||
| Pubmed | 7.65e-05 | 1431 | 45 | 9 | 37142655 | ||
| Pubmed | 9.48e-05 | 1139 | 45 | 8 | 36417873 | ||
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 14519125 | ||
| Pubmed | Reconstitution reveals the functional core of mammalian eIF3. | 1.07e-04 | 12 | 45 | 2 | 17581632 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.24e-04 | 605 | 45 | 6 | 28977666 | |
| Pubmed | 1.47e-04 | 206 | 45 | 4 | 22174317 | ||
| Pubmed | 1.47e-04 | 14 | 45 | 2 | 18599441 | ||
| Pubmed | 1.62e-04 | 399 | 45 | 5 | 35987950 | ||
| Pubmed | 1.70e-04 | 15 | 45 | 2 | 17322308 | ||
| Pubmed | Comparative mapping of two adjacent regions of MMU19 with their human counterpart on HSA11q13. | 1.70e-04 | 15 | 45 | 2 | 9730611 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.87e-04 | 1257 | 45 | 8 | 37317656 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 2.10e-04 | 226 | 45 | 4 | 25900982 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.13e-04 | 89 | 45 | 3 | 22446626 | |
| Pubmed | 2.17e-04 | 1285 | 45 | 8 | 35914814 | ||
| Pubmed | 2.20e-04 | 90 | 45 | 3 | 33087562 | ||
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 34752747 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.27e-04 | 1294 | 45 | 8 | 30804502 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 2.35e-04 | 92 | 45 | 3 | 10493829 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.57e-04 | 1318 | 45 | 8 | 30463901 | |
| Pubmed | 2.58e-04 | 441 | 45 | 5 | 31239290 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.60e-04 | 989 | 45 | 7 | 36424410 | |
| Pubmed | 2.76e-04 | 19 | 45 | 2 | 22267201 | ||
| Pubmed | 2.76e-04 | 19 | 45 | 2 | 24315451 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. | 2.76e-04 | 19 | 45 | 2 | 16597617 | |
| Pubmed | 3.06e-04 | 20 | 45 | 2 | 22174851 | ||
| Pubmed | 3.23e-04 | 723 | 45 | 6 | 34133714 | ||
| Pubmed | PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates. | 3.38e-04 | 21 | 45 | 2 | 39304345 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.47e-04 | 258 | 45 | 4 | 37794589 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 3.48e-04 | 1038 | 45 | 7 | 26673895 | |
| Pubmed | 3.72e-04 | 22 | 45 | 2 | 26748348 | ||
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 14517998 | ||
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 18320585 | ||
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 23322300 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 4.14e-04 | 1415 | 45 | 8 | 28515276 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 4.44e-04 | 24 | 45 | 2 | 30190310 | |
| Pubmed | 4.63e-04 | 116 | 45 | 3 | 30652415 | ||
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 4.63e-04 | 116 | 45 | 3 | 22810585 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.63e-04 | 774 | 45 | 6 | 15302935 | |
| Pubmed | 4.70e-04 | 1442 | 45 | 8 | 35575683 | ||
| Pubmed | FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. | 4.82e-04 | 25 | 45 | 2 | 20040496 | |
| Pubmed | Expression of Fgf signalling pathway related genes during palatal rugae development in the mouse. | 5.22e-04 | 26 | 45 | 2 | 20348033 | |
| Pubmed | Genetic loci influencing natural variations in femoral bone morphometry in mice. | 5.63e-04 | 27 | 45 | 2 | 11518254 | |
| Pubmed | 5.63e-04 | 27 | 45 | 2 | 19544582 | ||
| Pubmed | 6.50e-04 | 29 | 45 | 2 | 21876757 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 6.59e-04 | 1155 | 45 | 7 | 20360068 | |
| Pubmed | 6.90e-04 | 133 | 45 | 3 | 15144186 | ||
| Pubmed | Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. | 6.96e-04 | 30 | 45 | 2 | 20080650 | |
| Pubmed | 7.43e-04 | 31 | 45 | 2 | 16123981 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 9.02e-04 | 333 | 45 | 4 | 32665550 | |
| Pubmed | 9.04e-04 | 146 | 45 | 3 | 29509794 | ||
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 1.00e-03 | 36 | 45 | 2 | 16097034 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.02e-03 | 344 | 45 | 4 | 36282215 | |
| Pubmed | 1.04e-03 | 346 | 45 | 4 | 25324306 | ||
| Pubmed | 1.05e-03 | 347 | 45 | 4 | 17114649 | ||
| Pubmed | 1.05e-03 | 154 | 45 | 3 | 36490346 | ||
| Pubmed | A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. | 1.12e-03 | 38 | 45 | 2 | 18247557 | |
| Pubmed | 1.14e-03 | 613 | 45 | 5 | 22268729 | ||
| Pubmed | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. | 1.18e-03 | 160 | 45 | 3 | 23798571 | |
| Interaction | MIRLET7I interactions | 4.83e-06 | 114 | 44 | 5 | int:MIRLET7I | |
| Interaction | MIRLET7G interactions | 5.48e-06 | 117 | 44 | 5 | int:MIRLET7G | |
| Interaction | MIR138-1 interactions | 1.45e-05 | 68 | 44 | 4 | int:MIR138-1 | |
| Interaction | MIR9-3 interactions | 1.63e-05 | 70 | 44 | 4 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 1.73e-05 | 71 | 44 | 4 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.73e-05 | 71 | 44 | 4 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.73e-05 | 71 | 44 | 4 | int:MIR29B2 | |
| Interaction | MIR29B1 interactions | 1.93e-05 | 73 | 44 | 4 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 2.03e-05 | 74 | 44 | 4 | int:MIR20A | |
| Interaction | MIR15A interactions | 2.15e-05 | 75 | 44 | 4 | int:MIR15A | |
| Interaction | MIR7-3 interactions | 2.26e-05 | 76 | 44 | 4 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 2.26e-05 | 76 | 44 | 4 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 2.26e-05 | 76 | 44 | 4 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 2.26e-05 | 76 | 44 | 4 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 2.38e-05 | 77 | 44 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 2.38e-05 | 77 | 44 | 4 | int:MIR200A | |
| Interaction | MIR92A1 interactions | 2.51e-05 | 78 | 44 | 4 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 2.51e-05 | 78 | 44 | 4 | int:MIR98 | |
| Interaction | MIR451A interactions | 2.51e-05 | 78 | 44 | 4 | int:MIR451A | |
| Interaction | MIR222 interactions | 2.64e-05 | 79 | 44 | 4 | int:MIR222 | |
| Interaction | MIR206 interactions | 2.64e-05 | 79 | 44 | 4 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 2.64e-05 | 79 | 44 | 4 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 2.64e-05 | 79 | 44 | 4 | int:MIR34C | |
| Interaction | MIR143 interactions | 2.77e-05 | 80 | 44 | 4 | int:MIR143 | |
| Interaction | MIR145 interactions | 2.91e-05 | 81 | 44 | 4 | int:MIR145 | |
| Interaction | MIR106A interactions | 3.20e-05 | 83 | 44 | 4 | int:MIR106A | |
| Interaction | MIR31 interactions | 3.36e-05 | 84 | 44 | 4 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 3.36e-05 | 84 | 44 | 4 | int:MIR7-2 | |
| Interaction | MIR199A1 interactions | 3.36e-05 | 84 | 44 | 4 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 3.36e-05 | 84 | 44 | 4 | int:MIR200B | |
| Interaction | MIR107 interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR107 | |
| Interaction | MIR17 interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR17 | |
| Interaction | MIR18B interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR18B | |
| Interaction | MIR93 interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 3.52e-05 | 85 | 44 | 4 | int:MIR16-2 | |
| Interaction | MIR20B interactions | 3.68e-05 | 86 | 44 | 4 | int:MIR20B | |
| Interaction | MIR29A interactions | 3.85e-05 | 87 | 44 | 4 | int:MIR29A | |
| Interaction | MIR141 interactions | 4.03e-05 | 88 | 44 | 4 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 4.03e-05 | 88 | 44 | 4 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 4.21e-05 | 89 | 44 | 4 | int:MIR29C | |
| Interaction | MIR221 interactions | 4.40e-05 | 90 | 44 | 4 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 4.40e-05 | 90 | 44 | 4 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 4.40e-05 | 90 | 44 | 4 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 4.60e-05 | 91 | 44 | 4 | int:MIR200C | |
| Interaction | MIR155 interactions | 4.80e-05 | 92 | 44 | 4 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 4.80e-05 | 92 | 44 | 4 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 5.01e-05 | 93 | 44 | 4 | int:MIR214 | |
| Interaction | MIR205 interactions | 5.01e-05 | 93 | 44 | 4 | int:MIR205 | |
| Interaction | MIR19B2 interactions | 5.22e-05 | 94 | 44 | 4 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 5.22e-05 | 94 | 44 | 4 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 5.67e-05 | 96 | 44 | 4 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 5.91e-05 | 97 | 44 | 4 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 5.91e-05 | 97 | 44 | 4 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 5.91e-05 | 97 | 44 | 4 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 5.91e-05 | 97 | 44 | 4 | int:MIR363 | |
| Interaction | MIR106B interactions | 6.15e-05 | 98 | 44 | 4 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 6.40e-05 | 99 | 44 | 4 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 6.65e-05 | 100 | 44 | 4 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 6.92e-05 | 101 | 44 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 6.92e-05 | 101 | 44 | 4 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 6.92e-05 | 101 | 44 | 4 | int:MIR25 | |
| Interaction | KIRREL3 interactions | 6.95e-05 | 6 | 44 | 2 | int:KIRREL3 | |
| Interaction | MIRLET7A3 interactions | 7.19e-05 | 102 | 44 | 4 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 7.46e-05 | 103 | 44 | 4 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 7.46e-05 | 103 | 44 | 4 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 7.75e-05 | 104 | 44 | 4 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 7.75e-05 | 104 | 44 | 4 | int:MIR34A | |
| Interaction | MIRLET7E interactions | 8.35e-05 | 106 | 44 | 4 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 8.98e-05 | 108 | 44 | 4 | int:MIRLET7A1 | |
| Interaction | MIR34B interactions | 9.64e-05 | 110 | 44 | 4 | int:MIR34B | |
| Interaction | ZNF692 interactions | 1.05e-04 | 42 | 44 | 3 | int:ZNF692 | |
| Interaction | HSD11B2 interactions | 1.66e-04 | 9 | 44 | 2 | int:HSD11B2 | |
| Interaction | SPSB2 interactions | 1.88e-04 | 51 | 44 | 3 | int:SPSB2 | |
| Interaction | ICAM1 interactions | 2.14e-04 | 252 | 44 | 5 | int:ICAM1 | |
| Interaction | C1RL interactions | 2.53e-04 | 11 | 44 | 2 | int:C1RL | |
| Interaction | SMN1 interactions | 4.70e-04 | 299 | 44 | 5 | int:SMN1 | |
| Interaction | ANO3 interactions | 4.80e-04 | 15 | 44 | 2 | int:ANO3 | |
| Interaction | COPRS interactions | 5.00e-04 | 71 | 44 | 3 | int:COPRS | |
| Interaction | ANO7 interactions | 5.21e-04 | 72 | 44 | 3 | int:ANO7 | |
| Interaction | MIR18A interactions | 5.43e-04 | 73 | 44 | 3 | int:MIR18A | |
| Interaction | PCBP1 interactions | 5.76e-04 | 671 | 44 | 7 | int:PCBP1 | |
| Interaction | OCRL interactions | 5.81e-04 | 176 | 44 | 4 | int:OCRL | |
| Interaction | HIF1AN interactions | 6.13e-04 | 317 | 44 | 5 | int:HIF1AN | |
| Interaction | ADARB1 interactions | 6.39e-04 | 489 | 44 | 6 | int:ADARB1 | |
| Interaction | CDK11B interactions | 6.73e-04 | 183 | 44 | 4 | int:CDK11B | |
| Interaction | TPSB2 interactions | 6.97e-04 | 18 | 44 | 2 | int:TPSB2 | |
| Interaction | MIR10B interactions | 7.62e-04 | 82 | 44 | 3 | int:MIR10B | |
| Interaction | DDX43 interactions | 8.63e-04 | 20 | 44 | 2 | int:DDX43 | |
| Interaction | KLHL9 interactions | 9.67e-04 | 89 | 44 | 3 | int:KLHL9 | |
| Interaction | WDR77 interactions | 1.10e-03 | 361 | 44 | 5 | int:WDR77 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.53e-04 | 172 | 45 | 3 | chr16p12 | |
| Cytoband | 12p13.31 | 2.83e-03 | 80 | 45 | 2 | 12p13.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 5.04e-03 | 353 | 45 | 3 | chr12p13 | |
| Cytoband | 11q13 | 6.03e-03 | 118 | 45 | 2 | 11q13 | |
| GeneFamily | RNA binding motif containing | 1.95e-04 | 213 | 25 | 4 | 725 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.47e-06 | 193 | 45 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.20e-05 | 163 | 45 | 4 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 178 | 45 | 4 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.61e-05 | 185 | 45 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.61e-05 | 185 | 45 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.61e-05 | 185 | 45 | 4 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.77e-05 | 187 | 45 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.77e-05 | 187 | 45 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.85e-05 | 188 | 45 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 189 | 45 | 4 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.35e-05 | 194 | 45 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.44e-05 | 195 | 45 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 198 | 45 | 4 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.89e-05 | 200 | 45 | 4 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| Disease | – | 2.23e-04 | 16 | 41 | 2 | 611162 | |
| Disease | Malaria, susceptibility to | 2.23e-04 | 16 | 41 | 2 | cv:C1970028 | |
| Disease | Malaria | 3.52e-04 | 20 | 41 | 2 | C0024530 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 3.89e-04 | 21 | 41 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | malaria (is_implicated_in) | 5.10e-04 | 24 | 41 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | nitric oxide exhalation measurement | 1.28e-03 | 38 | 41 | 2 | EFO_0005536 | |
| Disease | childhood gender nonconformity | 1.64e-03 | 43 | 41 | 2 | EFO_0020103 | |
| Disease | Mitochondrial Diseases | 2.13e-03 | 49 | 41 | 2 | C0751651 | |
| Disease | Acute Cerebrovascular Accidents | 2.58e-03 | 54 | 41 | 2 | C0751956 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.86e-03 | 57 | 41 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | Cerebrovascular accident | 3.38e-03 | 62 | 41 | 2 | C0038454 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYYGGRGVGGIKRME | 381 | Q9H6X2 | |
| RVMLDYYREGQGGAG | 551 | Q8TD16 | |
| AMFGKSLRYAGYGEG | 516 | Q96NN9 | |
| RMLYGGRRCGNGYLE | 411 | Q9H013 | |
| GRFYGLDLYGGLHMD | 426 | Q8NEB7 | |
| RRMGGYYAGEVRTFP | 321 | C9J069 | |
| GRPGSYVYVFDGYRM | 651 | Q9NQ90 | |
| RRYYPGQGLGLMYFI | 336 | P80365 | |
| YGGRLCLGPMFEYQV | 586 | Q8WXS8 | |
| GGYGGKMGGRNDYRN | 571 | Q92804 | |
| LDGMNYLRYSLEGGR | 881 | Q01484 | |
| RYAGYQMPDGSIRGD | 266 | P35228 | |
| MNGEYRGRGFGRGRF | 1 | Q9UJA3 | |
| AGFERMRRGAYGGGY | 226 | P55795 | |
| VFPYMEGDRGSRYQG | 936 | O96028 | |
| GYFGMYRGAAVNLTL | 61 | Q9H936 | |
| MSQGRGKYDFYIGLG | 1 | Q8N8Q9 | |
| RGGYYGAGRGSMYDR | 121 | P31942 | |
| GALGLMYLYGQGIRQ | 211 | Q9P2M1 | |
| SGFYVAMNRRGRLYG | 91 | Q9HCT0 | |
| AGFERMRRGAYGGGY | 226 | P31943 | |
| GIGERYKFLQEMRGY | 436 | Q9Y5B6 | |
| KMYAIGGRVYEGDGR | 391 | Q8NFY9 | |
| MATGELGDLGGYYFR | 1 | Q9BRQ4 | |
| GYRKNEGYMRRGGYR | 891 | Q99613 | |
| DGYRKNEGYMRRGGY | 891 | B5ME19 | |
| WRLYGGMNYRRLGGG | 581 | Q9Y2M5 | |
| GRFGYLEGQEYRMYN | 521 | Q9HCG7 | |
| VLPFFGLGQMYIYRG | 341 | Q6PD62 | |
| LYRSGLLGYVSGFGM | 366 | Q9NZP8 | |
| DYRVYAAGGMGLDLR | 126 | Q8IYD2 | |
| GRLYDYGQRFVLGMG | 686 | Q8IZU9 | |
| GDGNLGVRGMALFFY | 296 | O00418 | |
| LYQFLMNGIRLGTYG | 71 | Q3KQZ1 | |
| RYLVGASGGVYALMG | 181 | Q9NX52 | |
| SGLGMAYLYGRGVQV | 451 | Q9UBV2 | |
| GRAMGARAAYIYIRG | 146 | P49821 | |
| SGLYLGMNERGELYG | 111 | O43320 | |
| YMTDGGLGLYTRRLN | 906 | Q8IVL1 | |
| TLRGNFYITGDRGYM | 451 | Q53FZ2 | |
| YLFHMYVGVRAGGGI | 4716 | Q15413 | |
| ERHAYIGGMFGAGIY | 1046 | Q9H2K2 | |
| LRFMYYVDGRGPDGG | 191 | P58753 | |
| AYGGGGRGMRVVHSY | 196 | P11498 | |
| RGEYLMDYDGSRRGL | 586 | C9JLR9 |